Bliss GVS Pharma Ltd Quarterly Results

Gross Sales

244.4

207.47

197.99

210.42

217.68

Excise Duty

0

0

0

0

0

Net Sales

244.4

207.47

197.99

210.42

217.68

Other Operating Income

0

0

0

0

0

Other Income

20.18

35.45

12.07

15.27

5.04

Total Income

264.58

242.92

210.05

225.68

222.72

Total Expenditure

212.64

166.14

176.9

180.63

176.2

PBIDT

51.94

76.78

33.15

45.05

46.51

Interest

3.04

5.47

1.68

1.08

3.83

PBDT

48.89

71.31

31.48

43.97

42.69

Depreciation

8.26

8.2

8.04

7.55

6.98

Minority Interest Before NP

0

0

0

0

0

Tax

14.31

20.49

5.9

13.76

11.09

Deferred Tax

-2.27

-1.75

0.89

-3.14

-1.08

Reported Profit After Tax

28.59

44.36

16.65

25.8

25.69

Minority Interest After NP

1.34

1.32

1.11

2

1.43

Net Profit after Minority Interest

27.25

43.04

15.54

23.8

24.26

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

27.25

43.04

15.54

23.8

24.26

EPS (Unit Curr.)

2.58

4.08

1.47

2.27

2.31

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.56

10.55

10.54

10.54

10.51

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

21.25

37

16.74

21.4

21.36

PBDTM(%)

20

34.37

15.89

20.89

19.61

PATM(%)

11.69

21.38

8.4

12.26

11.8